Demirkol, Mehmet Onur <br/><br/>
Local Salvage Treatment of Post-brachytherapy Recurrent Prostate Cancer via Theranostic Application of PSMA-labeled Lutetium-177.  [electronic resource] 

 -  Clinical genitourinary cancer  04 2018 
 - 99-102 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1938-0682 
<br/><br/><label>Standard No.: </label>10.1016/j.clgc.2017.09.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous<br/>Antigens, Surface--chemistry<br/>Brachytherapy<br/>Glutamate Carboxypeptidase II--chemistry<br/>Humans<br/>Lutetium--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--chemistry<br/>Prostate-Specific Antigen--metabolism<br/>Prostatic Neoplasms--chemistry<br/>Radioisotopes--administration & dosage<br/>Salvage Therapy<br/>Theranostic Nanomedicine<br/>Treatment Outcome